A variant of multifocal motor neuropathy with acute, generalised presentation and persistent conduction blocks

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 74, Issue 11, 2003, Pages 1555-1561

  Lefaucheur, J P ^a   Gregson, N A ^b   Gray, I ^b   Von Raison, F ^a   Bertocchi, M ^a   Creange A ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN; LAMIVUDINE; METHYLPREDNISOLONE; NELFINAVIR; RITUXIMAB; STAVUDINE;

ADULT; AREFLEXIA; ARTICLE; B CELL LYMPHOMA; CAMPYLOBACTER JEJUNI; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROPHYSIOLOGY; FEMALE; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIMB; MALE; MOTOR DYSFUNCTION; MOTOR NERVE; MOTOR NERVE BLOCK; MOTOR NERVE CONDUCTION; MOTOR NEUROPATHY; MULTIFOCAL MOTOR NEUROPATHY; NERVE BIOPSY; NERVE POTENTIAL; NONHODGKIN LYMPHOMA; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; QUADRIPLEGIA; SENSORY DYSFUNCTION; SENSORY NERVE; SENSORY NERVE CONDUCTION; SEROLOGY; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MOTOR NEURON DISEASE; NEURAL CONDUCTION; PARESIS;

EID: 0242441455     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.11.1555     Document Type: Article

References (42)

1. Parry GJ, Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 1988;11:103-7.
2. Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-8.
3. Parry GJ. AAEM Case report #30: multifocal motor neuropathy. Muscle Nerve 1996;19:269-76.
4. Pestronk A. Multifocal motor neuropathy: diagnosis and treatment. Neurology 1998;51(suppl):S22-4.
5. Jaspert A, Claus D, Grehl H, et al. Multifocal motor neuropathy: clinical and electrophysiological findings. J Neurol 1996;243:684-92.
6. Taylor BV, Wright RA, Harper CM, et al. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve 2000;23:900-8.
7. Pfeiffer G, Wicklein EM, Wittig K. Sensitivity and specificity of different conduction block criteria. Clin Neurophysiol 2000;111:1388-94.
8. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-4.
9. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 1997;48:321-8.
10. Ropert A, Metral S. Conduction block in neuropathies with necrotizing vasculitis. Muscle Nerve 1990;13:102-5.
11. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
12. Hafer-Macko C, Hsieh ST, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996;40:635-44.
13. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-42.
14. Brown WF, Feasby TE. Conduction block and denervation in Guillain-Barré polyneuropathy. Brain 1984;107:219-39.
15. Brown WF, Snow R. Patterns and severity of conduction abnormalities in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1991;54:768-74.
16. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985;6:504-9.
17. McLeod JG. Electrophysiological studies in the Guillain-Barré syndrome. Ann Neurol 1981;9(suppl):20-7.
18. Van Der Méché FGA, Meulstee J, Vermeulen M, et al. Patterns of conduction failure in the Guillain-Barré syndrome. Brain 1988;111:405-16.
19. Cornblath DR, Mellits ED, Griffin JW, et al. Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann Neurol 1988;23:354-9.
20. Ropper AH, Wijdicks EF, Shahani BT. Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barre syndrome. Arch Neurol 1990;47:881-7.
21. Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barré syndrome. Arch Neurol 2001;58:913-17.
22. Albers JW, Kelly Jr JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989;12:435-51.
23. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an ad hoc subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991;41:617-18.
24. Bromberg MB. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve 1991;14:968-76.
25. Cornblath DR, Chaudhry V, Griffin JW. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Ann Neurol 1991;30:104-6.
26. Gherardi R, Gaulard P, Prost C, et al. T-cell lymphoma revealed by a peripheral neuropathy. A report of two cases with an immunohistologic study on lymph node and nerve biopsies. Cancer 1986;58:2710-16.
27. Le Forestier N, LeGuern E, Coullin P, et al. Recurrent polyradiculoneuropathy with the 17p11.2 deletion. Muscle Nerve 1997;20:1184-6.
28. Roth G, Rohr J, Magistris MR, et al. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia. Eur Neurol 1986;25:416-23.
29. Van den Bergh P, Logigian EL, Kelly Jr JJ. Motor neuropathy with multifocal conduction blocks. Muscle Nerve 1989;12:26-31.
30. Beydoun SR, Rison RA, Commins D. Secondary amyloidosis as a life-ending event in multifocal motor neuropathy. Muscle Nerve 2001;24:1396-402.
31. Lewis RA, Sumner AJ, Brown MJ, et al. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982;32:958-4.
32. Abbruzzese M, Reni L, Schenone A, et al. Multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis. Neurology 1996;48:544.
33. White JR, Sachs GM, Gilchrist JM. Multifocal motor neuropathy with conduction block after Campylobacter jejuni. Neurology 1996;46:562-3.
34. Wohrle JC, Amoiridis G, Heye N, et al. Acute multifocal motor neuropathy with early spontaneous recovery: a distinct syndrome from Guillain-Barré syndrome? Electromyogr Clin Neurophysiol 1996;36:37-41.
35. Sugie K, Murata K, Ikoma K, et al. A case of acute multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis. Rinsho Shinkeigaku 1998;38:42-5.
36. Corcia P, Beaume A, Guennoc AM, et al. Neuropathie motrice aiguë démyélinisante secondaire à une gastro-entérite : une forme atypique de syndrome de Guillain-Barré? Rev Neurol (Paris) 1999;155:596-7.
37. Wijdicks EF, Ropper AH. Acute relapsing Guillain-Barré syndrome after long asymptomatic intervals. Arch Neurol 1990;47:82-4.
38. Yuki N. Anti-ganglioside antibody and neuropathy: review of our research. J Peripher Nerv Syst 1998;3:3-18.
39. Hadden RD, Gregson NA. Guillain-Barré syndrome and Campylobacter jejuni infection. Symp Ser Soc Appl Microbiol 2001;30(suppl):S145-54.
40. Chaudry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: response to human immune globulin. Ann Neurol 1993;33:237-42.
41. Nobile-Orazio E, Meucci N, Barbieri S, et al. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993;43:537-44.
42. Donaghy M, Mills KR, Boniface SJ, et al. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1994;57:778-83.